Leukowitch Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 207.79%
(FY 2022)
- Profit -133.90%
(FY 2022)
- Ebitda -66.95%
(FY 2022)
- Net Worth -15.88%
(FY 2022)
- Total Assets -8.39%
(FY 2022)
About Leukowitch Chemicals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akash Bhartiya and Sushil Bhartiya serve as directors at the Company.
- CIN/LLPIN
U24119MH2006PTC163995
- Company No.
163995
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Leukowitch Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akash Bhartiya  | Director | 02-Aug-2021 | Current |
| Sushil Bhartiya | Director | 19-Aug-2013 | Current |
Financial Performance of Leukowitch Chemicals.
Leukowitch Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 207.79% increase. The company also saw a substantial fall in profitability, with a 133.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leukowitch Chemicals?
In 2017, Leukowitch Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oxford Chemicals Private LimitedActive 37 years 10 monthsAkash Bhartiya and Sushil Bhartiya are mutual person
- Topaz Textile Auxilliaries Private LimitedActive 14 years 11 months
Akash Bhartiya and Sushil Bhartiya are mutual person
- Topaz Texchem Private LimitedActive 47 years 9 months
Akash Bhartiya and Sushil Bhartiya are mutual person
- Aapurti Chemicals Private LimitedActive 36 years 12 days
Akash Bhartiya and Sushil Bhartiya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Leukowitch Chemicals?
Unlock and access historical data on people associated with Leukowitch Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leukowitch Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leukowitch Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
